EBG Advisors provided a network of oncology practices with guidance regarding methods for the de-identification of protected health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.
The process of de-identification mitigates privacy risks to individuals and thereby supports the secondary use of data for comparative effectiveness studies, policy assessment, life sciences research, and other endeavors.
Under EBG Advisors’ guidance, the client successfully obtained a statistical opinion pursuant to the expert determination method under HIPAA to ensure its de-identification process is compliant and maintains data anonymity while balancing privacy and data utility.